BE841617A - Formes medicamenteuses solides, administrees par voie orale, de derives de xanthine solubles dans l'eau - Google Patents

Formes medicamenteuses solides, administrees par voie orale, de derives de xanthine solubles dans l'eau

Info

Publication number
BE841617A
BE841617A BE166873A BE166873A BE841617A BE 841617 A BE841617 A BE 841617A BE 166873 A BE166873 A BE 166873A BE 166873 A BE166873 A BE 166873A BE 841617 A BE841617 A BE 841617A
Authority
BE
Belgium
Prior art keywords
oral
water
solid drug
xanthine derivatives
drug forms
Prior art date
Application number
BE166873A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE841617A publication Critical patent/BE841617A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE166873A 1975-05-10 1976-05-07 Formes medicamenteuses solides, administrees par voie orale, de derives de xanthine solubles dans l'eau BE841617A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2520978A DE2520978C3 (de) 1975-05-10 1975-05-10 Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten

Publications (1)

Publication Number Publication Date
BE841617A true BE841617A (fr) 1976-11-08

Family

ID=5946306

Family Applications (1)

Application Number Title Priority Date Filing Date
BE166873A BE841617A (fr) 1975-05-10 1976-05-07 Formes medicamenteuses solides, administrees par voie orale, de derives de xanthine solubles dans l'eau

Country Status (12)

Country Link
US (1) US4189469A (de)
AU (1) AU502644B2 (de)
BE (1) BE841617A (de)
CY (1) CY1153A (de)
DE (1) DE2520978C3 (de)
DK (1) DK153918C (de)
FR (1) FR2310764A1 (de)
GB (1) GB1547232A (de)
HK (1) HK42382A (de)
KE (1) KE3219A (de)
MY (1) MY8600617A (de)
ZA (1) ZA762748B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491539A (en) * 1981-06-04 1985-01-01 The Procter & Gamble Company Liquid cleansing product with skin feel additives
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
WO1986006627A1 (en) * 1985-05-15 1986-11-20 Riker Laboratories, Inc. Sustained release theophylline compositions and processes
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
US5200193A (en) * 1987-04-22 1993-04-06 Mcneilab, Inc. Pharmaceutical sustained release matrix and process
US4820522A (en) 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5112827A (en) * 1990-05-18 1992-05-12 Board Of Regents, The University Of Texas System Drug to reverse fatty liver and atheromatous lesions
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
US5498802A (en) * 1995-02-28 1996-03-12 Hoechst Celanese Corporation Process for preparing omega-halo-ketones
US20040209900A1 (en) * 2003-04-15 2004-10-21 Hauptman Stephen P. Treatment of lipodystrophy (lipid redistribution syndrome)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
DE1617418C3 (de) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Herstellung von festen Arzneimittelformen mit verzögerter Wirkstoffabgabe
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3590117A (en) * 1969-03-24 1971-06-29 Richardson Merrell Inc Long-lasting troche containing guar gum
US3639169A (en) * 1969-04-29 1972-02-01 Sucrest Corp Direct compression vehicles and method therefor

Also Published As

Publication number Publication date
ZA762748B (en) 1977-04-27
DK153918B (da) 1988-09-26
AU502644B2 (en) 1979-08-02
DK205376A (da) 1976-11-11
HK42382A (en) 1982-10-08
MY8600617A (en) 1986-12-31
FR2310764B1 (de) 1980-07-11
FR2310764A1 (fr) 1976-12-10
GB1547232A (en) 1979-06-06
DE2520978B2 (de) 1980-06-12
DE2520978C3 (de) 1981-02-19
US4189469A (en) 1980-02-19
DK153918C (da) 1989-02-06
CY1153A (en) 1982-09-10
AU1376576A (en) 1977-11-17
KE3219A (en) 1982-08-13
DE2520978A1 (de) 1976-11-18

Similar Documents

Publication Publication Date Title
NL7808125A (nl) Farmaceutische preparaten van aluminiumzouten van ibuprofeen.
NL7607159A (nl) Werkwijzen voor de bereiding en toepassing van fenylazijnzuurderivaten.
NL190812C (nl) Werkwijze voor de bereiding van 1,4-dihydropyridinederivaten met vaatverwijdende en bloeddrukverlagende werking, alsmede farmaceutische preparaten die deze derivaten omvatten.
NL190721C (nl) Werkwijze voor het bereiden van 3-hydroxy-cephem derivaten.
NL7605749A (nl) Werkwijze voor de bereiding van 2,6-dimethyl-6- -gesubstitueerde heptaanderivaten.
BE841617A (fr) Formes medicamenteuses solides, administrees par voie orale, de derives de xanthine solubles dans l'eau
NO141411C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive erytromycin-derivater
NL7606120A (nl) Werkwijze voor de bereiding van farmacologisch werkzame heteroarylderivaten.
BE847044A (fr) Derives de l'acide clavulanique,
MX3743E (es) Procedimiento para la preparacion de derivados 3,4-dihidro-2 (lh)-quinazolinona
NL186162B (nl) Werkwijze voor de bereiding van organotitanaten en voor de bereiding van mengsels waarin deze organotitanaten worden gebruikt.
NL7807453A (nl) Halogeenmethylderivaten van alpha-aminozuren.
NL7812600A (nl) Werkwijze ter bereiding van guanidinederivaten.
BE838094A (fr) Preparation de colorants azoiques solubles dans l'eau
NL7606178A (nl) Werkwijze voor de bereiding van farmacologisch actieve heteroarylderivaten.
NL7608297A (nl) Werkwijze voor de bereiding en toepassing van derivaten van gesubstitueerde n-alkylimidazolen.
NL7610059A (nl) Werkwijze voor de bereiding van 4-oxo-4h-benzo- pyranderivaten.
NL7707515A (nl) Werkwijze voor de bereiding van cyanuurzuur- derivaten.
NL7613307A (nl) Werkwijze voor het bereiden van 2(1h)-chinazo- linonderivaten.
NL7605172A (nl) Werkwijze voor de bereiding van 2-(2,2-dihalo- geenvinyl)-3,3-dimethylcyclopropaan-1-gesub- stitueerde derivaten.
NL7610057A (nl) Werkwijze voor de bereiding van farmaceutische preparaten.
NL7710336A (nl) Werkwijze voor de bereiding van anthrachinon- derivaten.
NL7604330A (nl) Werkwijze voor de bereiding van 8-azaprostaan- zuurderivaten.
NO159273C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzotriazol-derivater.
NL7613714A (nl) Trifluormethyldhioderivaten van cyproheptadine.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: HOECHST A.G.

Effective date: 19960507